MS News & Perspectives

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with Tecfidera led to fewer relapses in relapsing-remitting multiple sclerosis patients than Aubagio or injectable immunomodulators. Plus, Price reads the column by John Connor, Fall Down, Get Up Again, “It’s Just One of Those MS ‘Snow Days’.” =================================== Are you interested in le...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how women with relapsing-remitting MS who stop fingolimod – sold as Gilenya – to conceive or in early pregnancy have a higher relapse risk. Also, Price reads “Once More, With Feeling: How Singing Can Benefit MS Patients”, a column by Jamie Hughes. =================================== Are you interested in learning mor...

Jenn Powell speaks with identical twins with MS Tamara Kahn and Terry Hord. Meet identical twins Tamara Kahn and Terry Hord. Identical in every way, both were diagnosed with multiple sclerosis twenty plus years ago. These two amazingly close sisters created “TwinsCoast2Coast” to inspire, empower, support, and educate others about the challenges of MS while also showing the positives that have foll...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about a study that indicates how people who develop colorectal cancer are more likely to die from it if they have multiple sclerosis. Also, Price reads “MS and Fertility: Conflicts of the Heart and Mind”, a column by Beth Ullah. =================================== Are you interested in learning more about...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article about how anti-CD20 antibody therapies that target B-cells are highly effective for reducing the risk of relapses in people with RRMS Also, Price reads “Thanks to a Wheelchair Mishap, I was ‘Busy Goin’ Nowhere’, a column by John Connor. =================================== Are you interested in learning m...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how oral fesoterodine fumarate tablets can reduce urinary disorders and improve quality of life for people with bladder impairment due to MS. Price also reads “Can Focusing on the Epstein-Barr Virus Help Researchers Fight MS?”, a column by Ed Tobias. =================================== Are you intereste...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how European Medicines Agency committee is recommending that Vumerity be approved for adults with relapsing-remitting multiple sclerosis in the EU; plus, Price reads the column by Jennifer Powell, Silver Linings, “When Loss Is Expected, How Do We Cope?”. ===================================== Are...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how rim lesions, thought to indicate chronic brain inflammation, were found in about 4 of every 10 patients; declined with age, disease duration; and reads “Despite the Nerves, I Attended My First Family Gathering in 2 Years”, a column by John Connor. =================================== Treatment for Relapsing MS Pro...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article about a class of molecules called positive allosteric modulators (PAMS) may be used to treat pain caused by nerve damage, a common symptom of MS. Price also reads a column by Ed Tobias, MS Wire, “I’m Sleeping Better These Days, but Why?”. =================================== Treatment for Relapsing MS Progr...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses an article on how bladder and bowel problems should be monitored regularly in MS patients to better adapt treatment plans and improve quality of life; plus, reads “Overcoming My Fear of Concerts With a Little Help From the Rolling Stones”, a column by Jennifer Powell. =================================== Treatment for...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how chronic Inflammation in MS can be linked to specific brain cells, a recent study showed; and also reads “All Change Please, the Medical Equipment You’re Using Ends Here”, a column by John Connor. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod) Rea...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about how a study found MS and depression doubled patients' vascular disease risk over 10 years, and relative to controls greatly raised risk of death. Also, Price Wooldridge, reads “I’m Grateful for My COVID-19 Booster Shot”, a column by Ed Tobias. =================================== Treatment for Rel...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge discusses an article about on how a study of immigrants with MS to Ontario, relative to residents with MS, found mood disorders and other comorbidities prevalent. Also, Price reads “Emotional and Physical Pain Are My Unwanted Sidekicks”, a column by Jennifer Powell. =================================== Treatment for Relapsing MS...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about how pro-inflammatory T helper 17 (Th17) immune cells directly interact with myelin-producing cells, promoting their damage and death. Price also reads “The Painful Tooth: My Weekend of Agony”, a column by John Connor. =================================== Treatment for Relapsing MS Progression | MAYZEN...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article on how people who had been infected with the T. gondii parasite were 32% less likely to develop multiple sclerosis than those who had not. Price also reads the column by Ed Tobias, MS Wire, “Researchers Lower the Temperature to Try to Reduce MS Inflammation”. =================================== Treatment f...

Follow us on social media! Instagram - https://www.instagram.com/msnewstoday/ Twitter - https://twitter.com/MSNewsToday Facebook - https://www.facebook.com/multiplesclerosisnewstoday/ Have you ever wondered who's behind the MS News Today social media platforms? Ally Macgregor chats with two of the folks behind MS News Today’s online community, Rochelle (@thisisrochelle) and Desiree Lama (@thedesla...

Follow us on social media! Instagram - https://www.instagram.com/msnewstoday/ Twitter - https://twitter.com/MSNewsToday Facebook - https://www.facebook.com/multiplesclerosisnewstoday/ Have you ever wondered who's behind the MS News Today social media platforms? Ally Macgregor chats with Ed Tobias (@themswire) and Arelis Castillo (@msconstruedfashion) about their roles as the social media coordinat...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how patients who had six weeks of vibration training have showed better cognitive function and life quality, and lesser disability in a small study; and reads “As My Disease Progresses, I Choose to Grow”, a column by Jennifer Powell. =================================== Treatment for Relapsing MS Progression | MAYZENT...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how National MS Society investments support 29 training fellowships, early career awards, and research projects aligned with its Pathways to Cures Roadmap; and reads “He’s Fallen in the Water!”, a column by John Connor. =================================== Treatment for Relapsing MS Progression | MAYZENT® (siponimod)...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about a how a Phase 3 trial analysis showed ADS-5102 significantly increased walking speed in 21% MS patients with difficulties; further work stopped. Also, Price Wooldridge reads “It’s Flu Vaccine Time Again, So Here’s What You Need to Know”, a column by Ed Tobias. ===================================...

Jenn Powell speaks with Director of Forums for SMA News Today, Kevin Schaefer Director of Forums for SMA News Today, Kevin Schaefer started at BioNews in 2017 as a columnist for SMA News Today, sharing his experiences as an adult with SMA Type 2. He eventually transitioned to a full-time role, helping build the company’s multimedia and forums divisions. Join Jenn and Kevin as they discuss commonal...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about experiencing serious infections during adolescence and how this can be tied to an increased risk of developing multiple sclerosis later in life. Price also reads “When Restless Legs Syndrome Won’t Leave You Alone”, a column by Jennifer Powell. =================================== Treatment for Rel...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses a news article about neurofilament light chain blood levels and cortical thinning on MRIs in recently diagnosed RRMS patients linked with poorer cognitive tests; and reads the column by John Connor, Fall Down, Get Up Again, “Down and Out in London Town!”. =================================== Treatment for Relapsing MS...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about BioNews Clinical, which aims to help clinical trials, essential to therapy, enroll people with rare and chronic disorders who want to participate. Price also reads “3 Things I Discovered at My 50th College Reunion”, a column by Ed Tobias. =================================== Treatment for Relapsing MS...

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads a news article about Belong. Life 's, a new i-Belong app that allows health professionals, advocacy groups, pharmas and others to build and manage patient communities. He also reads “Next Time, Ask Me Why I Need and Accessible Parking Placard”, a column by Jennifer Powell. =================================== Treatment fo...